Latch Bio
San Francisco, United States · Founded 2021 · $33.0M raised
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- latch.bio
- Total Funding
- $33.0M
- Last Round
- $28.0M Series AMay 2022
- Rounds
- 2
About
LatchBio is a modular cloud data and compute platform for biotech R&D teams, enabling scientists to store, analyze, and visualize multiomics data without deep engineering expertise. Built on an open-source Python SDK (Flyte-powered workflow orchestration), it supports bulk RNA-seq, gene editing, spatial biology, and more. Kit providers and biopharma labs use it to deliver white-labeled bioinformatics portals to their customers.
Summary
Latch Bio is a Biotech company based in San Francisco, United States, founded in 2021. It has raised $33.0M in total across 2 rounds, most recently a $28.0M Series A round in May 2022.
Tech & App Stack
7 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Databricks is the pioneer of the data lakehouse, a unified platform for data science, machine lea...
Quest Software (Nasdaq: QSFT) is a provider of application and information availability software ...
AI-powered enterprise cloud data management platform helping organizations integrate, catalog, go...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...